This week, these five stocks have the worst ratings in Cash Flow, one of the eight Fundamental Categories on Portfolio Grader.
Quicksilver Resources () is involved in the acquisition, development, exploration, production, and sale of natural gas and crude oil. KWK also gets F’s in Earnings Growth, Earnings Momentum, Operating Margin Growth and Sales Growth. Shares of the stock have declined 14.7% since January 1. This is worse than the S&P 500, which has seen a 12.1% increase over the same period. .
Top Life Sciences Stocks For 2015: Endologix Inc(ELGX)
Endologix, Inc. develops, manufactures, markets, and sells medical devices for the treatment of aortic disorders. It offers the ELG System, a stent graft and delivery system for the treatment of abdominal aortic aneurysms through minimally-invasive endovascular repair. The company also provides aortic extensions and limb extensions, which attach to the main body of ELG Device, enabling physicians to customize it to fit the patient?s anatomy. In addition, it offers accessories, such as guidewires, snares, and catheter introducer sheaths that facilitate the optimal delivery of its ELG Device. Endologix, Inc. sells its products through direct sales force and independent distributors in the United States, Europe, Asia, South America, and Mexico. The company was formerly known as Radiance Medical Systems, Inc. and changed its name to Endologix, Inc. in May 2002. Endologix, Inc. was founded in 1992 and is headquartered in Irvine, California.
Advisors' Opinion:- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Endologix (Nasdaq: ELGX ) , whose recent revenue and earnings are plotted below. - [By DailyFinance Staff]
Concerns about the political uncertainty in Ukraine caused some volatility in the markets Friday afternoon, with the major indexes making several U-turns ahead of the weekend. The Dow Jones industrial average (^DJI), which had been up by as much as 125 points, briefly dropped into loss territory before rebounding to end 49 points higher. The Standard & Poor's 500 index (^GPSC) edged up 5 points, adding to Thursday's record high, but the Nasdaq composite (^IXIC) lost 10 points. AP/Darko VojinovicPro-Russian militias have seized local government buildings in Crimea, Ukraine; the unrest there is making investors around the world nervous. February was a great month for investors. All three major averages jumped by about 4 percent. UnitedHealth Group (UNH) led the blue chips, gaining 1½ percent. Other health providers – Aetna (AET), Wellpoint (WLP), Cigna (CI) and Humana (HUM) -- all gained between 1½ and 2 percent. And retail stocks remained active. Target (TGT) added another 3 percent. Best Buy rose 4 percent, and Fred's (FRED), a regional department store chain, jumped 10 percent. But Pier 1 (PIR) fell 5½ percent after lowering its earnings outlook for a second time. That led to a series of brokerage downgrades. Decker Outdoor (DECK) tumbled 12 percent. The maker of footwear brands such as Ugg and Teva issued a weak outlook. And apparel maker Lululemon (LULU) fell 5-percent on negative comments from Credit Suisse. It seems as though there are always some big movers in the drug and biotech sectors – and that was certainly the case today. GW Pharmaceuticals (GWPH) rose 2 percent after the FDA granted orphan status to its drug to treat a rare form of childhood epilepsy. But most of the action was on the downside. Endologix (ELGX) slid 24 percent after forecasting lower revenue growth. Questcor (QCOR) fell 10 percent. It's lost big for three straight days amid allegations of questionable business practices. Jazz Pharma
- [By Jake L'Ecuyer]
Equities Trading DOWN
Shares of Endologix (NASDAQ: ELGX) were down 24.85 percent to $13.43 on lowered guidance, analyst downgrades. Oppenheimer downgraded the stock from Outperform to Market Perform and cut the price target from $20.00 to $16.00. - [By Jake L'Ecuyer]
Equities Trading DOWN
Shares of Endologix (NASDAQ: ELGX) were down 23.48 percent to $13.68 on lowered guidance, analyst downgrades. Oppenheimer downgraded the stock from Outperform to Market Perform and cut the price target from $20.00 to $16.00.
Top 5 Healthcare Technology Stocks To Buy Right Now: Green Dot Corporation (GDOT)
Green Dot Corporation operates as a bank holding company. It offers general purpose reloadable prepaid debit cards, and cash loading and transfer services in the United States. The company�s products include Green Dot MasterCard, Visa-branded prepaid debit cards, and various co-branded reloadable prepaid card programs; Visa-branded gift cards; and MoneyPak and swipe reload proprietary products that enable cash loading and transfer services through its Green Dot Network. Its Green Dot Network enables consumers to use cash to reload its prepaid debit cards or to transfer cash to any of the company�s Green Dot Network acceptance members, including competing prepaid card programs, and other online accounts. The company markets its cards and financial services to banked, underbanked, and unbanked consumers. Green Dot Corporation offers its products and services through retail distributors, including mass merchandisers, drug store and convenience store chains, and supermarket chains; the Internet; and relationships with other businesses. Its prepaid debit cards and prepaid reload services are available to consumers at approximately 60,000 retail locations nationwide and online at greendot.com. The company was formerly known as Next Estate Communications, Inc. and changed its name to Green Dot Corporation in October 2005. Green Dot Corporation was incorporated in 1999 and is headquartered in Pasadena, California.
Advisors' Opinion:- [By Dan Newman]
Even with Radiohead's questionable outcome with the scheme,�Green Dot's� (NYSE: GDOT ) GoBank, launched in January, is offering checking accounts where its members decide what to pay as a monthly fee, between $0 and $9. Does this make any sense for the company to think customers will voluntarily pay?
- [By Amanda Alix]
Despite Walmart's (NYSE: WMT ) success with prepaid debit cards through partnerships with Green Dot (NYSE: GDOT ) and American Express (NYSE: AXP ) , the retail giant has never quite been able to break into the ranks of the big boys through the launch of its own retail bank. Now, an article on Bloomberg makes this conundrum crystal clear: Banks advising the Federal Reserve have lobbied against making such a plan a reality.
Top 5 Healthcare Technology Stocks To Buy Right Now: Gen-Probe Incorporated(GPRO)
Gen-Probe Incorporated engages in the development, manufacture, and marketing of molecular diagnostic products and services that are used primarily to diagnose human diseases and screen donated human blood. Its women?s health product line includes APTIMA Combo 2 assay, APTIMA CT, APTIMA GC assays, and PACE family of assays to detect chlamydia and gonorrhea; APTIMA Trichomonas ASRs to detect trichomonas; APTIMA HPV assay to detect 14 sub-types of high-risk HPV associated with cervical cancer; and AccuProbe Group B Streptococcus (GBS) assay to detect GBS from culture. The company?s infectious diseases product line comprises ProFlu+ to detect influenza A, B, and Respiratory syncytial virus; ProFAST+ to detect and differentiate seasonal H1, seasonal H3, and H1N1pdm09; ProGastro Cd to detect toxigenic strains of clostridium difficile; AMPLIFIED MTD to detect mycobacterium tuberculosis; GAS Direct to detect gas directly from a throat swab; APTIMA HIV-1 and APTIMA HCV assays to detect RNA from HIV-1 and hepatitis C virus; and ASRs for quantitative HCV testing. Its blood screening products include Procleix HIV-1/HCV, Procleix Ultrio, Procleix Ultrio Plus, and Procleix WNV assays to detect HIV-1, HCV, HBV, and west nile virus in donated blood, plasma, organs, and tissues. The company?s transplant diagnostics products comprise LIFECODES HLA DNA typing kits; LIFECODES HLA antibody kits; LIFECODES PF4 assay to detect PF4 heparin-dependent antibodies; and LIFECODES PAK products for platelet antibody screening and detection. It also provides instrumentation and software for performing NAT assays; and genetic testing products, such as PROGENSA PCA3 and PCA3 ASRs to detect the PCA3 genes. The company serves reference laboratories, public health institutions, and hospitals through its direct sales force in United States, Canada, and Europe, as well as through distributors internationally. Gen-Probe Incorporated was founded in 1983 and is headquartered in S an Diego, California.
Advisors' Opinion:- [By Jesse Solomon]
Further, as companies take advantage of a rising stock market and ultra-low interest rates, mergers and acquisitions activity and initial public offerings have been hot this year. GoPro (GPRO) is the latest mega success, having jumped 50% since its debut on Thursday.
- [By WWW.DAILYFINANCE.COM]
Seth Wenig/APCEO Nick Woodman holds a GoPro camera in his mouth as he celebrates his GoPro's IPO. There were plenty of winners and losers this week, as the leading premium coffeehouse chain expanded its carbonated beverage offerings, and a disruptive video-streaming service got disrupted itself. Here's a rundown of the week's best and worst. GoPro (GPRO) -- Winner The initial public offering market got some fresh meat on Thursday when GoPro went public. The company behind the popular namesake cameras that extreme sports enthusiast like to wear was a hit. It priced at $24 a share -- at the high end of its initial range -- and that still wasn't enough. The stock opened at $28.65, closing out its first day of trading with a 31 percent gain. GoPro's growth has been stellar. Sales soared 87 percent last year to nearly hit $1 billion. However, there was a surprising decline in revenue during this year's first quarter. New GoPro investors are assuming that the most recent quarter's dip was a fluke. If it isn't a fluke, they can record their stumble in glorious high-def. Aereo -- Loser Sometimes it's the disruptor that gets disrupted. Aereo, the start-up service that offers local TV channels as a streaming platform, was pummeled by the U.S. Supreme Court. In a 6-3 decision, the court ruled that Aereo violated the copyrights of major TV networks by streaming their content without paying transmission fees. The move isn't the end for Aereo, but its prognosis has clearly deteriorated. Aereo thought that incorporating tiny remote antennas that subscribers can access online was similar enough to actual HD antenna ownership by individuals that its business model would be found to be legal. That didn't pan out, and consumers are unlikely to get a break this way from their ever-increasing cable and satellite TV bills. Starbucks (SBUX) -- Winner If you need to cool down in the Sun Belt, Starbucks has a few fizzy options. The java giant this week introduced its Fizzio lin
Top 5 Healthcare Technology Stocks To Buy Right Now: Journal Communications Inc. (JRN)
Journal Communications, Inc. operates as a media company in the United States. Its Broadcasting segment operates approximately 34 radio stations and 15 television stations in 12 states; and 1 television station under marketing agreement. Its television and radio stations provide targeted and relevant local programming to serve listeners, viewers, and advertisers. The company�s Publishing segment publishes Milwaukee Journal Sentinel, which serves as the daily newspaper for the Milwaukee metropolitan area; and various community newspapers and shoppers in Wisconsin. Its Milwaukee Journal Sentinel newspaper is distributed through independent contract carriers and agents. The company also operates various Websites, including JSOnline.com and Milwaukeemoms.com, and the MyCommunityNOW family of 26 community Websites that provide editorial and advertising content. In addition, it publishes niche publications for advertisers and readers in the agricultural market; and offers comme rcial printing services, including cold-Web printing, sheet-fed printing, electronic prepress, mailing, bindery, and inserting for other weekly and monthly publications. Journal Communications, Inc. was founded in 1882 and is headquartered in Milwaukee, Wisconsin.
Advisors' Opinion:- [By Jayson Derrick]
The E.W. Scripps Company (NYSE: SSP) and Journal Communications (NYSE: JRN) announced that the two companies will merge their broadcast operations and plan to spin off the new entity as a new publicly-traded company. In addition, the newspaper businesses will combine to form a new company called Journal Media Group. Shares of E.W. Scripps hit new 52-week highs of $22.66 before closing the day at $21.68 while shares of Journal Communications also hit new 52-week highs of $11.37 before closing the day at $10.88, up 24.20 percent.
- [By Garrett Cook]
Journal Communications (NYSE: JRN) shares were also up, gaining 24.66 percent to $10.92. The E.W. Scripps Company (NYSE: SSP) and Journal Communications have agreed to merge their broadcasting operations and spin off their newspapers businesses into a separate publicly held company.
No comments:
Post a Comment